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wall. Only one patient developed third degree AV block which
required temporary pacing.
Conclusion: Early intervention if neccessarywhen the patient is in
sinus rhythm. Adequate rate control by pharmacological means
before subjecting the pts to PTMC. Optimizing the dose of digoxin
so that it neither causes brady arrhythmia, at the same time
preventing tachyarrhythmias. Every effort to bemade to avoid low
puncture, balloon slippage and inadvertent manipulation of
guidewires and catheters. One must be ready to do pacing if
warrented. Meticulous pre procedural evaluation, patient prepa-
ration and careful handling of hardwares will prevent arrhythmia
related complications.
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Background: After Percutaneous transvenous mitral commissur-
otomy (PTMC), symptomatic mitral valve restenosis develops in 4
to 39 % cases. The current study aims to identify demographic,
clinical characteristics, echocardiographic parameters that may
predict the successful result of redo PTMC in post-PTMC symp-
tomatic mitral restenosis.
Methods: Single centre retrospective observational study of in
hospital patients in last 5 years Successful PTMC was defined as
MVA> 1.5 cm2 without a postprocedural MR grade>2 using 2D
Echocardiography.
Results: There were 324 patients (230 females, 94 males); mean
age 33 (12 to 59 years). Median time interval from the initial pro-
cedure was 8.3 yrs (0.6 to 19 yrs).261 (80%) were in NYHA class II.
271(84%) were in sinus rhythm and 53(16%) in atrial fibrillation.
Successful PTMC was seen in 251(77.5 %) patients. Mean Wilkin
score was 9.9. There was a significant increase in the mean MVA
from 1.0 to 1.6 cm2, mean.RVSP decreased significantly from 52 to
36 mm Hg. Four patients developed severe MR and three under-
went emergency MVR. 6 patients developed cardiac tamponade
requiring pericardiocentesis and one had femoral artery throm-
bosis treated conservatively. There were no in-hospital deaths or
systemic embolisation. Unsuccessful PTMC was seen in 73(22.5%)
patients. These unsuccessful results were due to post procedure
MR grade >2 in 4 patients (1.2%) and suboptimal secondary MVA
<1.5 cm2 in 69 patients (21.3%). Predictors of poor outcome were-
Right ventricular dysfunction in 16, severe tricuspid regurgitation
in 10,Wilkin scores with severe subvalvular fusion in 63 &high
calcium score in 20 patients.
Conclusion: Redo PTMC in patients with mitral restenosis is
feasible safe procedure with good success rate and optimal results
with acceptable morbidity. In patients with low echo scores and
no comorbid diseases, repeat PTMC should be the procedure of
choice. For patients with more extensive valvular and subvalvular
deformity, redo PTMC can be used as a palliative technique in
these patients when they are at high risk of morbidity and mor-
tality with MVR due to the presence of associated significant co-
morbid diseases.
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Background: Rheumatic heart disease is a common problem in
developing countries. Plasma BNPlevels are affected in rheumatic
heart disease, and can be correlated with disease severity.
Aims: To correlate levels of NT pro BNP with echocardiographic
(including LA strain and strain rate (S/Sr) and hemodynamic pa-
rameters of LA functions and with improvement with PBMV with
intermediate term follow up of 1 year.
Methods: 48 patients of severe MS undergoing PBMV were
enrolled. All subjects underwent detailed history, physical ex-
amination. All the tests were done within 12 hours prior to PBMV
and repeated 12 hours post PBMV, at 1 month and at 1 year.
Transthoracic echo was performed using Vivid 7 echocardio-
graphic unit (GE) Tissue Doppler Echocardiography derived S/Sr
imaging were used for assessment of LA regional longitudinal
function using apical 2- and 4-chamber views. Peak S/Sr were
measured at each mid-LA segment (septal, lateral, anterior, and
inferior) during ventricular systole (LAs) and at early (LAe) and late
diastole (LAa). LAA contraction velocity was calculated using trans
esophageal echocardiography and correlated with NT pro BNP
levels. Invasively, cardiac output was calculated using Swan-Ganz
Standard Thermodilution Pulmonary Artery Catheter and Vigi-
lance II moniter. PCWP, pulmonary artery pressure and other cath
data were correlated with NT pro BNP levels pre and post PBMV.
Results: Mean PrePBMV NTproBNP was 700 pg/ml. Mean level 1
day post PBMV was 425pg/ml, and after 1 month 300pg/ml(p<.05).
At 1 year the levels of NTproBNPwere 50pgm/ml. S/Sr at eachmid-
LA segment (septal, lateral, anterior, and inferior) during ven-
tricular systole (LAs), at early (LAe) and late diastole (LAa) were
significantly lower in the patients than in the controls (P < 0.0001)..
S/Sr values improved significantly (p < 0.05) in most segments at
day 1 and at post PTMC 1 month. At 1 year these values showed
more than 50% increase that was related significantly with NT pro
BNP levels. , Also fall in mean pulmonary artery pressure, fall in
PCWP and rise in cardiac output, all correlated significantly with
NT pro BNP levels.
Conclusion: NT pro BNP levels correlate significantly with LA
dysfunction and predict improvement in LA function post PBMV
in Rheumatic mitral stenosis even at 1 year.
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Background: Mitral regurgitation (MR) causes progressive systolic
and diastolic LV dysfunction and has negative impacts on the
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